Obgyn Key

Uterine Sarcomas   Gary S. Leiserowitz   Sarcomas comprise approximately 3% to 7% of uterine corpus malignancies. Although they represent a small proportion of uterine cancers, they disproportionately contribute to…

Cancer in Pregnancy   Malaika Amneus and Christine H. Holschneider   The diagnosis of cancer complicates approximately 1 in 1000 pregnancies. Once diagnosed, emotional, ethical, diagnostic, and treatment dilemmas confront…

Genetics and Biology of Gynecologic Cancers   Douglas A. Levine   All cancer is genetic, meaning that all cancers have a genetic basis and result from an accumulation of mutations…

Epidemiology of Gynecologic Cancers, Clinical Trials, and Statistical Considerations   Wendy R. Brewster and Krishnansu S. Tewari   EPIDEMIOLOGY OF GYNECOLOGIC CANCERS   The burden of cancer on our population…

Preinvasive Disease of the Lower Genital Tract   Levi S. Downs Jr. and Jori S. Carter   Over the past 3 decades, the work of population scientists, laboratory-based researchers, and…

Vulvar Cancer   Mark Milam and Charles F. Levenback   Vulvar cancers are among the least common gynecologic malignancies. Radical surgery is the primary approach for most patients, and advances…

Metastases to the Gynecologic Tract   S. Diane Yamada and Nita K. Lee   Metastases to the genital tract may occur as a result of recognizable widely disseminated disease from…

Surgical Instrumentation and Sutures   John C. Elkas and Addie Alkhas   It is imperative that surgeons understand the choice and limitations of their instruments and sutures with regard to…

Management of the Adnexal Mass   Ritu Salani and Christa Nagel   Uterine adnexae are defined as the areas adjacent to the uterus that are occupied by the fallopian tubes…

Gestational Trophoblastic Disease   Diljeet K. Singh   Gestational trophoblastic disease (GTD) represents a spectrum of cellular proliferations arising from the villous trophoblast of the placenta and encompasses 4 clinicopathologic…